Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  1996-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00042737-199606000-00010PMID 8823568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man

  2004cited by this paper
• Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.

  1994cited by this paper
• Review article: topical corticosteroids in inflammatory bowel disease

  1993cited by this paper
• Veterinary services in Africa.

  1993cited by this paper
• Pituitary-adrenal function during corticosteroid therapy. Learning to live with uncertainty.

  1992cited by this paper
• A controlled trial of beclomethasone versus betamethasone enemas in distal ulcerative colitis.

  1991cited by this paper
• Long-term use of mesalamine enemas to induce remission in ulcerative colitis.

  1990cited by this paper
• Formulation and stability of a beclomethasone dipropionate enema

  1989cited by this paper
• Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis. An adrenocortical approach.

  1989cited by this paper
• Topical treatment of ulcerative proctitis with lidocaine.

  1989cited by this paper
• Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis.

  1988cited by this paper
• Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial.

  1988cited by this paper
• Treatment of distal ulcerative colitis with beclomethasone enemas: High therapeutic efficacy without endocrine side effects

  1987cited by this paper
• A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

  1987cited by this paper
• Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function.

  1983cited by this paper
• Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression.

  1982cited by this paper
• Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

  1981cited by this paper
• A double blind controlled trial of prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitis

  1962cited by this paper
• Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial.

  1958cited by this paper

• British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025

  2025cites this paper
• Appropriate use and complications of corticosteroids in inflammatory bowel disease: A comprehensive review.

  2025cites this paper
• Treatment of Ulcerative Colitis: Induction of Remission, Maintenance, and Management of the Remission Period

  2025cites this paper
• Morbus Crohn und Colitis ulcerosa

  2025influential citation
• Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2)

  2024cites this paper
• Management and treatment optimization of patients with mild to moderate ulcerative colitis

  2023cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009

  2023cites this paper
• Corticosteroids in inflammatory bowel disease: are they still a therapeutic option?

  2023cites this paper
• GADECCU 2022 Guideline for the treatment of Ulcerative Colitis. Adaptation and updating of the GETECCU 2020 Guideline.

  2023cites this paper
• Optimizing treatment of mild to moderate ulcerative colitis: CU-Forum Delphi Consensus.

  2023cites this paper
• Anorectal Strictures in Complex Perianal CD: How to Approach?

  2022cites this paper
• An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis

  2022cites this paper
• Corticosteroids in Inflammatory Bowel Disease: Are they still a therapeutic option?

  2022cites this paper
• Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial

  2022cites this paper
• Development and validation of HPLC-DAD and LC-(ESI)/MS methods for the determination of sulfasalazine, mesalazine and hydrocortisone 21-acetate in tablets and rectal suppositories: In vitro and ex vivo permeability studies.

  2022cites this paper
• ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

  2021cites this paper
• Efficacy of pharmacological agents for ulcerative proctitis: a systematic literature review.

  2021cites this paper
• Drug development for ulcerative proctitis: current concepts

  2021cites this paper
• When disease extent is not always a key parameter: Management of refractory ulcerative proctitis

  2021cites this paper
• Efficacy of Budesonide Foam in Patients with Mild-to-Moderate Ulcerative Colitis Treated with a Maximum Dose of Oral Mesalazine

  2021cites this paper
• Guía GETECCU 2020 para el tratamiento de la colitis ulcerosa. Elaborada con metodología GRADE

  2020cites this paper
• Die Anwendung von Natural Language Processing zur kompakten Erfassung einer Krankheit

  2020cites this paper
• Steroid use and misuse: a key performance indicator in the management of IBD

  2020cites this paper
• Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento tópico en la colitis ulcerosa

  2020cites this paper
• Management of Isolated Anal Strictures in Crohn’s Disease

  2020cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline

  2020cites this paper
• Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease

  2020cites this paper
• GETECCU 2020 guidelines for the treatment of ulcerative colitis. Developed using the GRADE approach.

  2020cites this paper
• Modern use of 5-aminosalicylic acid compounds for ulcerative colitis

  2020cites this paper
• Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis

  2020cites this paper
• Macrophage-based nanotherapeutic strategies in ulcerative colitis.

  2020cites this paper
• A Comprehensive Review of Topical Therapies for Distal Ulcerative Colitis.

  2020cites this paper
• A comprehensive review and update on ulcerative colitis.

  2019cites this paper
• Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis

  2019cites this paper
• Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS)

  2019cites this paper
• 2019 Expert opinion on biological treatment use in inflammatory bowel disease management.

  2019cites this paper
• An update on treatment of ulcerative colitis

  2019cites this paper
• AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.

  2019cites this paper
• Medical Treatment of Ulcerative Colitis: Does Traditional Therapy Still Have a Role?

  2019cites this paper
• Comparison of the efficiency of different enemas on patients with distal ulcerative colitis

  2019cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa

  2019cites this paper
• Ulcerative Colitis: Current and Emerging Treatment Strategies

  2019cites this paper
• Enfermedad Inflamatoria Intestinal al Día REVISIÓN Recomendaciones sobre el uso e indicaciones del tratamiento tópico en pacientes con colitis ulcerosa

  2019cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa

  2019cites this paper
• Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2019cites this paper
• The treatment of refractory ulcerative colitis.

  2018cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

  2018cites this paper
• Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis

  2018cites this paper
• Nonbiological therapeutic management of ulcerative colitis

  2018cites this paper
• Ulcerative Proctitis and Anorectal Crohn’s Disease

  2018cites this paper
• The safety of beclomethasone dipropionate in the treatment of ulcerative colitis

  2018cites this paper
• American Gastroenterological Association Institute Guideline on the Management of Mild-Moderate Ulcerative Colitis

  2018cites this paper
• Pharmacotherapy of ulcerative colitis – current status and emerging trends

  2018cites this paper
• Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.

  2017cites this paper
• The Use of 5-Aminosalicylic Acid in Children and Adolescents With Inflammatory Bowel Disease

  2017cites this paper
• Ulcerative colitis

  2017cites this paper
• Second Korean guidelines for the management of ulcerative colitis

  2017cites this paper
• Développement de formulations polymériques de S-nitrosoglutathion comme traitement per os pour prévenir les maladies inflammatoires chroniques de l’intestin

  2017cites this paper
• Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study

  2017cites this paper
• Sulfasalazine and 5-Aminosalicylates for Ulcerative Colitis

  2017cites this paper
• Conventional Therapy of Ulcerative Colitis: Corticosteroids

  2017cites this paper
• [Second Korean Guideline for the Management of Ulcerative Colitis].

  2017cites this paper
• Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis

  2017cites this paper
• Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

  2017cites this paper
• Gastroenterología y Hepatología

  2016cites this paper
• Efficacy of Combined Mesalazine Plus Corticosteroid Enemas for Diversion Colitis after Subtotal Colectomy for Ulcerative Colitis

  2016cites this paper
• Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease.

  2016cites this paper
• Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis

  2016cites this paper
• Drug-Delivery-Strategien zur gezielten Behandlung von chronisch-entzündlichen Darmerkrankungen

  2015cites this paper
• Beclomethasone dipropionate for the treatment of ulcerative colitis

  2015influential citation
• Efficacy of mesalazine or beclomethasone dipropionate enema or their combination in patients with distal active ulcerative colitis.

  2015cites this paper
• Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.

  2015cites this paper
• Medical Therapy of Active Ulcerative Colitis

  2015cites this paper
• Drug-Delivery-Strategien zur gezielten Behandlung von chronisch-entzündlichen Darmerkrankungen Drug delivery strategies for targeted treatment of inflammatory bowel disease

  2015cites this paper
• [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)].

  2015cites this paper
• Conventional drug therapy for inflammatory bowel disease

  2015cites this paper
• Optimal use of corticosteroids in gastroenterology and hepatology

  2014cites this paper
• Ulcerative proctitis: an update on the pharmacotherapy and management

  2014cites this paper
• Managing Intractable Proctitis and the Problematic Pouch

  2014cites this paper
• Principles of Medical Management of Ulcerative Colitis

  2014cites this paper
• Rectal Glucocorticoid Use in Ulcerative Colitis

  2014cites this paper
• Treatment of Distal/Left-Sided Ulcerative Colitis

  2014cites this paper
• Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitis

  2014cites this paper
• Recurrent cholangitis in a 65-year-old man

  2014cites this paper
• Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implications.

  2014cites this paper
• Glucocorticoid therapy for gastrointestinal diseases

  2014cites this paper
• Optimisation de la prise en charge de la rectocolite hémorragique : de la théorie à la pratique

  2014influential citation
• Topical therapy is underused in patients with ulcerative colitis.

  2014cites this paper
• "Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion.

  2014cites this paper
• Ulcerative colitis: current pharmacotherapy and future directions

  2014cites this paper
• Classical and recent advances in the treatment of inflammatory bowel diseases

  2014cites this paper
• Topische Therapie bei chronisch-entzündlichen Darmerkrankungen

  2014cites this paper
• Topische Therapie bei chronisch-entzündlichen Darmerkrankungen

  2013cites this paper
• The GETECCU clinical guideline for the treatment of ulcerative colitis:: A guideline created using GRADE methodology

  2013cites this paper
• Review article: strategies for the management of chronic unremitting ulcerative colitis

  2013cites this paper
• Management and treatment of distal ulcerative colitis

  2013cites this paper
• PPAR-gamma in ulcerative colitis: a novel target for intervention.

  2013cites this paper
• [Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU].

  2013cites this paper
• Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU.

  2013cites this paper
• Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity

  2013influential citation